메뉴 건너뛰기




Volumn 22, Issue 2, 2003, Pages 159-167

The costs of not treating hepatitis C virus infection in injecting drug users in New Zealand

Author keywords

Hepatitis C; Intravenous drug use

Indexed keywords

ABORIGINE; ADOLESCENT; ADULT; AGED; ARTICLE; COMMUNITY CARE; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEPATITIS C; HUMAN; LIFE EXPECTANCY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; NEW ZEALAND; ORGANIZATION AND MANAGEMENT; STATISTICS; SUBSTANCE ABUSE;

EID: 0041909548     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595230100100598     Document Type: Article
Times cited : (11)

References (30)
  • 2
    • 0029145541 scopus 로고
    • Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme
    • Chetwynd J, Brunton C, Blank M et al. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. NZ Med J 1995;108:364-366.
    • (1995) NZ Med J , vol.108 , pp. 364-366
    • Chetwynd, J.1    Brunton, C.2    Blank, M.3
  • 3
    • 0035958778 scopus 로고    scopus 로고
    • Prevalence of hepatitis B and C infection in a methadone clinic population: Implications for hepatitis B vaccination
    • Carter H, Robinson G, Hanlon C et al. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination. NZ Med J 2001;114:324-6.
    • (2001) NZ Med J , vol.114 , pp. 324-326
    • Carter, H.1    Robinson, G.2    Hanlon, C.3
  • 4
    • 0032756280 scopus 로고    scopus 로고
    • Modelling the hepatitis C virus epidemic in Australia
    • Law MG. Modelling the hepatitis C virus epidemic in Australia. J Gastroenterol Hepatol 1999;14:1100-7.
    • (1999) J Gastroenterol Hepatol , vol.14 , pp. 1100-1107
    • Law, M.G.1
  • 5
    • 0030885637 scopus 로고    scopus 로고
    • Natural history of hepatitis C
    • Seef LB. Natural history of hepatitis C. Hepatology 1997;26(Suppl. 1): 21S-8.
    • (1997) Hepatology , vol.26 , Issue.SUPPL. 1
    • Seef, L.B.1
  • 6
    • 0001445884 scopus 로고    scopus 로고
    • Statement management of hepatitis C
    • National Institutes of Health Consensus Development Conference Panel. Statement Management of Hepatitis C. Hepatology 1997;26(Suppl.1): 2S-10.
    • (1997) Hepatology , vol.26 , Issue.SUPPL.1
  • 7
    • 0033799722 scopus 로고    scopus 로고
    • Estimating future hepatitis C morbidity, mortality, and costs in the United States
    • Wong JB, McQuillan GM, McHutchison et al. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-9.
    • (2000) Am J Public Health , vol.90 , pp. 1562-1569
    • Wong, J.B.1    McQuillan, G.M.2    McHutchison3
  • 8
    • 0031748381 scopus 로고    scopus 로고
    • Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users
    • Brown K, Crofts N. Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users. Aust NZ J Public Health 1998;22:384-8.
    • (1998) Aust NZ J Public Health , vol.22 , pp. 384-388
    • Brown, K.1    Crofts, N.2
  • 9
    • 30244569635 scopus 로고    scopus 로고
    • Economic analyses for hepatitis C: A review of Australia's response
    • Lowe D, Cotton R, eds. ch. 7. Canberra: Department of Health and Aged Care, Commonwealth of Australia
    • Shiell A. Economic analyses for hepatitis C: a review of Australia's response. In: Lowe D, Cotton R, eds. Hepatitis C: a review of Australia's response, ch. 7. Canberra: Department of Health and Aged Care, Commonwealth of Australia, 1999.
    • (1999) Hepatitis C: A Review of Australia's Response
    • Shiell, A.1
  • 10
    • 0032562295 scopus 로고    scopus 로고
    • Hepatitis B virus carrier prevalence in New Zealand: Population estimates using the 1987 police and customs personnel survey
    • Blakely T, Salmond C, Tobias M. Hepatitis B virus carrier prevalence in New Zealand: population estimates using the 1987 police and customs personnel survey. NZ Med J 1998;111:142-4.
    • (1998) NZ Med J , vol.111 , pp. 142-144
    • Blakely, T.1    Salmond, C.2    Tobias, M.3
  • 11
    • 0032502422 scopus 로고    scopus 로고
    • Chronic hepatitis B virus infection in South Auckland
    • Gane E. Chronic hepatitis B virus infection in South Auckland. NZ Med J 1998;111:120-3.
    • (1998) NZ Med J , vol.111 , pp. 120-123
    • Gane, E.1
  • 12
    • 0028872317 scopus 로고
    • Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin
    • Bar-Shany S, Green MS, Slepon R et al. Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin. J Viral Hepatitis 1995;2:139-44.
    • (1995) J Viral Hepatitis , vol.2 , pp. 139-144
    • Bar-Shany, S.1    Green, M.S.2    Slepon, R.3
  • 13
    • 0032570368 scopus 로고    scopus 로고
    • Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations
    • Kemp R, Miller J, Lungley S et al. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations. NZ Med J 1998;111:50-3.
    • (1998) NZ Med J , vol.111 , pp. 50-53
    • Kemp, R.1    Miller, J.2    Lungley, S.3
  • 14
    • 0033607711 scopus 로고    scopus 로고
    • Methadone maintenance treatment: Outcomes from the Otago methadone programme
    • Dore GM, Walker JD, Paice JR et al. Methadone maintenance treatment: outcomes from the Otago methadone Programme. NZ Med J 1999;112:442-5.
    • (1999) NZ Med J , vol.112 , pp. 442-445
    • Dore, G.M.1    Walker, J.D.2    Paice, J.R.3
  • 15
    • 0028823771 scopus 로고
    • Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
    • Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology 1995;22:1863-73.
    • (1995) Hepatology , vol.22 , pp. 1863-1873
    • Dusheiko, G.M.1    Roberts, J.A.2
  • 16
    • 0028918747 scopus 로고
    • Cost-effectiveness of interferon alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B
    • Wong JB, Koff RS, Tine F et al. Cost-effectiveness of Interferon alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B. Ann Int Med 1995;122:664-75.
    • (1995) Ann Int Med , vol.122 , pp. 664-675
    • Wong, J.B.1    Koff, R.S.2    Tine, F.3
  • 17
    • 0032731788 scopus 로고    scopus 로고
    • Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C
    • Younossi ZM, Singer ME, McHutchison JG et al. Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C. Hepatology 1999;30:1318-23.
    • (1999) Hepatology , vol.30 , pp. 1318-1323
    • Younossi, Z.M.1    Singer, M.E.2    McHutchison, J.G.3
  • 18
    • 0034124763 scopus 로고    scopus 로고
    • Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C
    • Wong JB, Poynard T, Ling MH et al. Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. Am J Gastroenterol 2000;95:1524-30.
    • (2000) Am J Gastroenterol , vol.95 , pp. 1524-1530
    • Wong, J.B.1    Poynard, T.2    Ling, M.H.3
  • 19
    • 0034177475 scopus 로고    scopus 로고
    • Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
    • Wong JB, Davis GL, Pauker SG. Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C. Am J Med 2000;108:366-73.
    • (2000) Am J Med , vol.108 , pp. 366-373
    • Wong, J.B.1    Davis, G.L.2    Pauker, S.G.3
  • 21
    • 0028998145 scopus 로고
    • Clinical outcomes after transfusion-associated hepatitis C
    • Tong MJ, El-Farra NS, Reikes AR et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-6.
    • (1995) N Engl J Med , vol.332 , pp. 1463-1466
    • Tong, M.J.1    El-Farra, N.S.2    Reikes, A.R.3
  • 22
    • 0034802218 scopus 로고    scopus 로고
    • Estimating progression to cirrhosis in chronic hepatitis C virus infection
    • Freeman AJ, Dore GJ, Law MG et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34:809-16.
    • (2001) Hepatology , vol.34 , pp. 809-816
    • Freeman, A.J.1    Dore, G.J.2    Law, M.G.3
  • 23
    • 84990602616 scopus 로고
    • Mortality of intravenous drug users: Attenders of the Wellington drug clinic, 1972-89
    • Dukes PD, Robinson GM, Robinson BJ. Mortality of intravenous drug users: attenders of the Wellington drug clinic, 1972-89. Drug Alcohol Rev 1992;11:197-201.
    • (1992) Drug Alcohol Rev , vol.11 , pp. 197-201
    • Dukes, P.D.1    Robinson, G.M.2    Robinson, B.J.3
  • 24
    • 30244440565 scopus 로고    scopus 로고
    • This publication uses the Australian version of ICD 9-CMA-II. Wellington: Ministry of Health
    • Ministry of Health. Mortality and demographic data 1996. This publication uses the Australian version of ICD 9-CMA-II. Wellington: Ministry of Health, 1997.
    • (1997) Mortality and Demographic Data 1996
  • 26
    • 0028047786 scopus 로고
    • The cost-effectiveness of alpha interferon in the treatment of chronic active hepatitis C
    • Shiell A, Briggs A, Farrell GC. The cost-effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust 1994;160:268-72.
    • (1994) Med J Aust , vol.160 , pp. 268-272
    • Shiell, A.1    Briggs, A.2    Farrell, G.C.3
  • 28
    • 4644345404 scopus 로고    scopus 로고
    • Gaining control of the hepatitis C virus epidemic in Australia
    • Crofts N, Dore G, Locarnini S, eds. ch. 22. Melbourne: IP Communications
    • Crofts N, Wodak A. Gaining control of the hepatitis C virus epidemic in Australia. In: Crofts N, Dore G, Locarnini S, eds. Hepatitis C: an Australian perspective, ch. 22. Melbourne: IP Communications, 2001.
    • (2001) Hepatitis C: An Australian Perspective
    • Crofts, N.1    Wodak, A.2
  • 29
    • 0028933065 scopus 로고
    • Methadone maintenance treatment: Coming of age in New Zealand
    • Sellman D, Deering D, Robinson G. Methadone maintenance treatment: coming of age in New Zealand. NZ Med J 1995;108:128-30.
    • (1995) NZ Med J , vol.108 , pp. 128-130
    • Sellman, D.1    Deering, D.2    Robinson, G.3
  • 30
    • 0023092811 scopus 로고
    • Compensated cirrhosis: Natural history and prognostic factors
    • Gines P, Quinterro E, Arroyo V et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122-28.
    • (1987) Hepatology , vol.7 , pp. 122-128
    • Gines, P.1    Quinterro, E.2    Arroyo, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.